Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice

Keyphrases

• Astaxanthin 100%
• Ischemia-reperfusion Injury 100%
• Steatotic Liver 100%
• Inflammatory Cytokines 57%
• Heme oxygenase-1 (HO-1) 42%
• High-fat Diet 28%
• Hypoxia 28%
• Hepatocytes 28%
• Protective Effect 28%
• Deoxygenation 28%
• Methionine 28%
• Choline-deficient 28%
• Liver 14%
• Apoptosis 14%
• Signaling Pathway 14%
• Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) 14%
• Akt Phosphorylation 14%
• Liver Transplantation 14%
• Hypoxia-inducible factor-1α (HIF-1α) 14%
• MRNA Level 14%
• TUNEL 14%
• Reactive Oxygen Species 14%
• Caspase Activation 14%
• ERK Phosphorylation 14%
• Mammalian Target of Rapamycin (mTOR) 14%
• Serum ALT 14%
• Apoptosis-related Proteins 14%
• ERK MAPK 14%
• Kupffer 14%
• B-cell Lymphoma 2 (Bcl-2) 14%
• Lipid Peroxidation 14%
• 4-hydroxynonenal (4-HNE) 14%
• Kupffer Cells 14%
• Therapeutic Treatment 14%
• Steatosis 14%
• Liver Model 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Reperfusion Injury 100%
• Astaxanthin 100%
• Cytokine 57%
• Heme Oxygenase 1 42%
• Hypoxia 28%
• Methionine 28%
• Choline 28%
• Reactive Oxygen Metabolite 14%
• Caspase 14%
• Steatosis 14%
• Transcription Factor Nrf2 14%
• Messenger RNA 14%

Immunology and Microbiology

• Reperfusion 100%
• Inflammatory Cytokine 80%
• Heme 60%
• Reoxygenation 40%
• Caspase 20%
• Liver Transplantation 20%
• Signal Transduction 20%
• Bcl-2 20%
• Transcription Factor Nrf2 20%
• Lipoapoptosis 20%
• Lipid Peroxidation 20%
• Kupffer Cell 20%